Based on scientific data showing that HPV testing provides better protection against cervical
precancer and cancer than cytology, in 2011 the Dutch Health Council advised the Minister …

Primary HPV screening for cervical cancer by HPV mRNA testing (Aptima) was implemented
in January 2017, for women≥ 30 through 70 years, in the Region of Skåne, Sweden. HPV …

Objective The aim of this study was to evaluate the performance of human papillomavirus
(HPV)‐based screening in the framework of an organised cervical cancer screening …

In a previous letter published in Swiss Medical Weekly, we emphasised the need for
Switzerland to change from cytology-based to human papillomavirus (HPV) screening for …

Background Human papillomavirus (HPV) testing is increasingly used as the primary
cervical cancer screening test. In a large pilot implementation, we compared participation …

Objectives To compare the short-term and long-term effectiveness of human papillomavirus
(HPV) tests in Norwegian Cervical Cancer Screening Programme (NCCSP). Design …

The identification of HPV as the cause of cervical cancer has changed the information
required for surveillance. HPV prevalence and screening uptake worldwide are now …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Introduction In randomized studies, testing for high‐risk (HR) human papillomavirus (hrHPV)
has been more sensitive than conventional cytology in detecting cervical intraepithelial …

Italian recommendations on HPV testing were based on a Health Technology assessment
report published in 2012.1 It included a section on efficacy and undesired effects, based on …